Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01604031
Title Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide
Acronym TAIL
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Baylor College of Medicine
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.